BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19169238)

  • 1. 23-Gauge transconjunctival sutureless pars plana vitrectomy: results of a prospective study.
    Schweitzer C; Delyfer MN; Colin J; Korobelnik JF
    Eye (Lond); 2009 Dec; 23(12):2206-14. PubMed ID: 19169238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy.
    Lai MM; Ruby AJ; Sarrafizadeh R; Urban KE; Hassan TS; Drenser KA; Garretson BR
    Retina; 2008 May; 28(5):729-34. PubMed ID: 18463517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion.
    Riemann CD; Miller DM; Foster RE; Petersen MR
    Retina; 2007 Mar; 27(3):296-303. PubMed ID: 17460584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [23-gauge transconjunctival sutureless vitrectomy: a retrospective study of 164 consecutive cases].
    de Preobrajensky N; Mrejen S; Adam R; Ayello-Scheer S; Gendron G; Rodallec T; Sahel JA; Barale PO
    J Fr Ophtalmol; 2010 Feb; 33(2):99-104. PubMed ID: 20080319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
    Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
    Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease.
    Fine HF; Iranmanesh R; Iturralde D; Spaide RF
    Ophthalmology; 2007 Jun; 114(6):1197-200. PubMed ID: 17544779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sutureless transconjunctival 20-gauge vitrectomy].
    Dassie-Ajdid J; Mahieu L; Mathis V; Arné JL; Auriol S
    J Fr Ophtalmol; 2011 Dec; 34(10):729-36. PubMed ID: 22001624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of 20-gauge transconjunctival sutureless vitrectomy.
    Papaefthymiou I; Petropoulos IK; Mangioris G; Mendrinos E; Pournaras CJ
    Ophthalmologica; 2013; 230(4):207-14. PubMed ID: 24029384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
    Khan MA; Shahlaee A; Toussaint B; Hsu J; Sivalingam A; Dugel PU; Lakhanpal RR; Riemann CD; Berrocal MH; Regillo CD; Ho AC
    Am J Ophthalmol; 2016 Jan; 161():36-43.e1-2. PubMed ID: 26429584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratometric alterations following the 25-gauge transconjunctival sutureless pars plana vitrectomy versus the conventional pars plana vitrectomy.
    Citirik M; Batman C; Bicer T; Zilelioglu O
    Clin Exp Optom; 2009 Sep; 92(5):416-20. PubMed ID: 19549227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOVEL TECHNIQUE FOR SECURING SCLEROTOMIES IN 20-GAUGE TRANSCONJUNCTIVAL PARS PLANA VITRECTOMY: Surgical Outcomes and Complications in 529 Consecutive Cases.
    Abouammoh MA; Abouammoh MA; Gale JS; Arevalo JF; Sharma S
    Retina; 2016 May; 36(5):974-80. PubMed ID: 26509222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary 23-gauge transconjunctival sutureless vitrectomy for rhegmatogenous retinal detachment.
    Tsang CW; Cheung BT; Lam RF; Lee GK; Yuen CY; Lai TY; Lam DS
    Retina; 2008 Oct; 28(8):1075-81. PubMed ID: 18779713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 23-gauge transconjunctival sutureless vitrectomy: visual outcomes and complications.
    Mateo-Montoya A; Mendrinos E; Tabatabay C; Pournaras CJ
    Semin Ophthalmol; 2011 Mar; 26(2):37-41. PubMed ID: 21469961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy.
    Tewari A; Shah GK; Fang A
    Retina; 2008 Feb; 28(2):258-62. PubMed ID: 18301031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy system.
    Kapran Z; Acar N
    Retina; 2007 Oct; 27(8):1059-64. PubMed ID: 18040245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease.
    Khan MA; Kuley A; Riemann CD; Berrocal MH; Lakhanpal RR; Hsu J; Sivalingam A; Ho AC; Regillo CD
    Ophthalmology; 2018 Mar; 125(3):423-431. PubMed ID: 29146307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion.
    Toygar O; Mi CW; Miller DM; Riemann CD
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2111-2118. PubMed ID: 27094701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcomes of 110 consecutive 25-gauge transconjunctival sutureless pars plana vitrectomies].
    Guyomarch J; Delyfer MN; Korobelnik JF
    J Fr Ophtalmol; 2008 May; 31(5):473-80. PubMed ID: 18641579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.